Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Adoptive Cell Therapy

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials

Cell Therapy

From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials

Dominic Mancini

OrganaBio

PAO-01-25-CL-13Jan 28, 2025

Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses

Microbiome

Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses

Stacy Burns-Guydish, Ph.D.

List Labs

PAO-10-23-CL-07-33Nov 01, 2023

Taking Adoptive Cell Therapies to the Next Level

Cell Therapy

Taking Adoptive Cell Therapies to the Next Level

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-022--NI-04Jun 24, 2022

Expanding Access to Cell Therapies with a Patient-Centric Focus

Cell Therapy

Expanding Access to Cell Therapies with a Patient-Centric Focus

Amy L. Ronneberg

Be The Match BioTherapies

PAO-02-022-CL-12Mar 12, 2022